Author

Xueliang Yu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:host-pathogen & immune response· 1 Assay:multiome· 1 Organism:rat· 1

Frequent Co-Authors

Huarong Bai· 2 shared Qin LiiD· 2 shared Rongkuan HuiD· 2 shared Qiang LiuiD· 1 shared Yubin Zhao· 1 shared Yue Gao· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Huarong Bai

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studies

Huarong Bai, Qin Li, Yue Gao, Yubin Zhao, Xueliang Yu, Rongkuan Hu

This paper evaluates an mRNA-based RSV preF vaccine, STR-V003, showing robust immunogenicity, safety, and protective immunity in preclinical studies, leading to FDA approval for phase I clinical trials.

Vaccines · Jun 10, 2025Peer-reviewedPharmacology & Toxicology

Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle Targeting Lipid Nanoparticles in Mice

Qin Li, Huarong Bai, Xueliang Yu, Qiang Liu, Rongkuan Hu

This study evaluates an mRNA vaccine encoding the Rabies Virus G-protein formulated with muscle-targeting lipid nanoparticles, showing high immunogenicity and protection in mice.

Vaccines · Feb 22, 2025Peer-reviewedPharmacology & Toxicology